Diabetic retinopathy: Pathogenesis
Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss the disease processes that lead to retinopathy in people with diabetes (9:11).
Learning points include:
- Modifiable versus non-modifiable risk factors of diabetic retinopathy.
- Current understanding of the pathophysiology of diabetic retinopathy and prospective therapeutic targets.
- Why rapid improvements in glycemic control may contribute to the pathogenesis of diabetic retinopathy.